Novartis Ag (NVS) Gross Margin (2009 - 2025)

Novartis Ag (NVS) has 15 years of Gross Margin data on file, last reported at 81.93% in Q2 2025.

• Quarterly Gross Margin rose 441.0% year-over-year to 81.93% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 77.1% (down 1074805.0% YoY) and the FY2025 annual result came in at 78.81%, up 151.0% from the prior year.
• Gross Margin grew to 81.93% in Q2 2025 per NVS's latest filing, from 76.92% in the prior quarter.
• The five-year high for Gross Margin was 13229571.98% in Q1 2022, with the low at 393700.79% in Q4 2022.
• Average Gross Margin over 5 years is 1057382.39%, with a median of 73.75% recorded in 2023.
• Year-over-year, Gross Margin jumped 1322956700 bps in 2022 and plunged 1168636211 bps in 2023.
• Novartis Ag's Gross Margin stood at 0.06% in 2021, then plunged by 713357805 bps to 393700.79% in 2022, then soared by 100 bps to 74.02% in 2023, then climbed by 4 bps to 76.92% in 2024, then grew by 7 bps to 81.93% in 2025.
• Business Quant data shows NVS's Gross Margin at 81.93% in Q2 2025, 76.92% in Q4 2024, and 77.52% in Q2 2024.